RE:52 Week Low
Trillium Therapeutics Inc's average diluted shares outstanding for the quarter that ended in Sep. 2016 was 7.82 Mil. Trillium Therapeutics Inc's net cash per share for the quarter that ended in Sep. 2016 was $4.71 USD or $6.20 CAD Trading at $8.74 CAD Company, clinical studies and intellectual property is worth $2.54 CAD The market is essentially saying that the intellectual property is worthless. A effing joke.